ARCHIVES

Cytogen Corp.’s Imaging Agent ProstaScint Added to NCCN Prostate Cancer Guidelines.

This article is from The Cancer Letter archive.

Vol. 26 No. 13 | March 31, 2000

Download PDF Visit The Full Archive

Related Articles

NCI selects nanotech centers for funding.

October 14, 2005

Non-Profit Spent $1.3 Million On Consultants.

March 28, 2008

DCT Board Approves $8 Million In Contract Projects For Recompetition

October 31, 1980

Reagan Family History Shows String Risk Factor

August 2, 1985

CDC Funds Early Detection Programs In Eight States

August 23, 1991

Frank Torti Named FDA Deputy Commissioner, To Take Leave As Wake Forest Center Director.

April 11, 2008